Lym-X-Sorb powder ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
299Cystic fibrosis1

299. Cystic fibrosis


Clinical trials : 1,696 Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00406536
(ClinicalTrials.gov)
January 200729/11/2006Study of LYM-X-SORB™ to Improve Fatty Acid and Choline Status in Children With CF and PIPhase II Study: LYM-X-SORB™, an Organized Lipid Matrix: Fatty Acids and Choline in CFCystic Fibrosis;Pancreatic InsufficiencyDietary Supplement: Lym-X-Sorb powder;Dietary Supplement: Placebo powderAvanti Polar Lipids, Inc.National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed6 Years17 YearsBoth110Phase 2United States